prof. Sophie Vanhaesebrouck
- ORCID iD
-
0000-0002-6372-0115
Show
Sort by
-
Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial) : a multicentre, randomised controlled trial
-
Understanding meropenem disposition in critically ill children : a population PK analysis
-
Characterizing meropenem pharmacokinetics in paediatric critical care patients : a population-based analysis
-
- Journal Article
- A1
- open access
Trends in neonatal morbidity and mortality for very low birthweight infants : a 20-year single-center experience
-
- Journal Article
- A1
- open access
Pregnancy termination at a viable stage in daily clinical practice : a nationwide mortality follow‐back study in Flanders, Belgium
-
Association of antenatal magnesium sulfate with reduced late-onset sepsis in extreme preterm infants
-
Suboptimal beta-lactam therapy in critically ill children : risk factors and outcome
-
Cranial ultrasound and MRI : complementary or not in the diagnostic assessment of children with congenital CMV infection?
-
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units
-
Critically ill children treated with beta-lactam antibiotics : how to identify patients at risk for suboptimal exposure and clinical failure?